IP Verse

Biotest patent opposition analysis

CompanyCompetitive AnalysisCompany Patent Opposition Analysis

Latest oppositions filed by Biotest

Explore patent oppositions filed by Biotest against competitors, revealing strategic technology disputes and market positioning. Monitor opposition details, timelines, and disputed innovations to understand competitive dynamics and IP enforcement strategy.

Last updated on: Aug 28, 2025
Patent NumberTitleApplicantOpposition Date

Get instant updates on new opposition filings by the company

EP3506915
Human Blood-Derived Products Having Decreased Fibrinolytic Activity And Uses Thereof In Hemostatic DisordersPLAS FREEDec 5, 2024
EP3481415
Stable Liquid FibrinogenLABORATOIRE FRANAIS DU FRACTIONNEMENT ET DES BIOTECHNOLOGIESJun 5, 2024
EP2945962
Methods For Isolating Blood Products From An Inter-Alpha Inhibitor Protein-Depleted Blood Product MaterialPROTHERA BIOLOGICSJan 17, 2020
EP2670429
Method For Inactivation/Removal Of Coagulation Factors By PrecipitationOCTAPHARMADec 21, 2018
EP2825555
Improved Process For Production Of Fibrinogen And Fibrinogen Produced TherebyOCTAPHARMAApr 12, 2018

Top competitors of Biotest

Top competitors of Biotest based on patent oppositions.